Cowen to host conference call to discuss first quarter 2021 financial results on Thursday, April 29. Click here for more information.

Street Cred Ep 9 | Ad Com for COVID-19: Vaccines Likely to Underwhelm

Rick Weissenstein, health care policy analyst at Cowen Washington Research Group looks at the latest in health care policy on Capitol Hill and the administration this month. In this episode, he speaks with Mike McCaughan, Founding Partner of Prevision Policy about what to expect from the FDA advisory committee meeting to discuss the COVID-19 vaccines on October 22nd, how the upcoming election could affect the FDA and the impact of executive orders on drug pricing.

Press play below to listen to their conversation.

Get the Full Report

If you’re already a member of our Research portal, log in.

Log In

If not, reach out to us directly for more information.

More Like This

Video
Ahead of the Curve®

Biden’s First 100 Days

Read More
Video
Themes 2021

Consumer Transformation

Read More
Ahead of the Curve®

Closing Time: You Don’t Have to Go Home, but You Can’t Eat Here

Read More